Follow
Thomas Urup
Thomas Urup
Unknown affiliation
Verified email at regionh.dk
Title
Cited by
Cited by
Year
A comprehensive profile of recurrent glioblastoma
B Campos, LR Olsen, T Urup, HS Poulsen
Oncogene 35 (45), 5819-5825, 2016
2572016
VEGF-C sustains VEGFR2 activation under bevacizumab therapy and promotes glioblastoma maintenance
SR Michaelsen, M Staberg, H Pedersen, KE Jensen, W Majewski, ...
Neuro-oncology 20 (11), 1462-1474, 2018
792018
The prognostic value of FET PET at radiotherapy planning in newly diagnosed glioblastoma
SH Poulsen, T Urup, K Grunnet, IJ Christensen, VA Larsen, ML Jensen, ...
European journal of nuclear medicine and molecular imaging 44, 373-381, 2017
742017
Recurrent glioblastoma versus late posttreatment changes: diagnostic accuracy of O-(2-[18F]fluoroethyl)-L-tyrosine positron emission tomography (18F-FET PET)
A Bashir, S Mathilde Jacobsen, O Mølby Henriksen, H Broholm, T Urup, ...
Neuro-oncology 21 (12), 1595-1606, 2019
542019
The impact of bevacizumab treatment on survival and quality of life in newly diagnosed glioblastoma patients
HS Poulsen, T Urup, SR Michaelsen, M Staberg, M Villingshøj, U Lassen
Cancer management and research, 373-387, 2014
532014
Treatment with docetaxel and cisplatin in advanced adrenocortical carcinoma, a phase II study
T Urup, WZ Pawlak, PM Petersen, H Pappot, M Rørth, G Daugaard
British journal of cancer 108 (10), 1994-1997, 2013
392013
Cancer stem cells and the cellular hierarchy in haematological malignancies
HE Johnsen, MK Kjeldsen, T Urup, K Fogd, L Pilgaard, M Boegsted, ...
European journal of cancer 45, 194-201, 2009
382009
Toxicity and efficacy of lomustine and bevacizumab in recurrent glioblastoma patients
JN Jakobsen, T Urup, K Grunnet, A Toft, MD Johansen, SH Poulsen, ...
Journal of neuro-oncology 137, 439-446, 2018
372018
Molecular profiling of short-term and long-term surviving patients identifies CD34 mRNA level as prognostic for glioblastoma survival
SR Michaelsen, T Urup, LR Olsen, H Broholm, U Lassen, HS Poulsen
Journal of Neuro-oncology 137, 533-542, 2018
352018
Angiotensinogen and HLA class II predict bevacizumab response in recurrent glioblastoma patients
T Urup, SR Michaelsen, LR Olsen, A Toft, IJ Christensen, K Grunnet, ...
Molecular Oncology 10 (8), 1160-1168, 2016
272016
Transcriptional changes induced by bevacizumab combination therapy in responding and non-responding recurrent glioblastoma patients
T Urup, LM Staunstrup, SR Michaelsen, K Vitting-Seerup, M Bennedbæk, ...
BMC cancer 17, 1-10, 2017
252017
A prognostic model for glioblastoma patients treated with standard therapy based on a prospective cohort of consecutive non-selected patients from a single institution
AA Abedi, K Grunnet, IJ Christensen, SR Michaelsen, A Muhic, S Møller, ...
Frontiers in oncology 11, 597587, 2021
242021
Development and validation of a prognostic model for recurrent glioblastoma patients treated with bevacizumab and irinotecan
T Urup, RH Dahlrot, K Grunnet, IJ Christensen, SR Michaelsen, A Toft, ...
Acta Oncologica 55 (4), 418-422, 2016
192016
Predicting survival of glioblastoma from automatic whole-brain and tumor segmentation of MR images
S Pálsson, S Cerri, HS Poulsen, T Urup, I Law, K Van Leemput
Scientific Reports 12 (1), 19744, 2022
182022
DNA Methylation Levels of the ELMO Gene Promoter CpG Islands in Human Glioblastomas
SR Michaelsen, D Aslan, T Urup, HS Poulsen, K Grønbæk, H Broholm, ...
International Journal of Molecular Sciences 19 (3), 679, 2018
142018
18F-FET MicroPET and MicroMRI for Anti-VEGF and Anti-PlGF Response Assessment in an Orthotopic Murine Model of Human Glioblastoma
MK Nedergaard, SR Michaelsen, T Urup, H Broholm, H El Ali, HS Poulsen, ...
PLoS One 10 (2), e0115315, 2015
132015
Outcome of bevacizumab therapy in patients with recurrent glioblastoma treated with angiotensin system inhibitors
MD Johansen, T Urup, CB Holst, IJ Christensen, K Grunnet, U Lassen, ...
Cancer Investigation 36 (9-10), 512-519, 2018
122018
A systematic review of targeted therapy for vestibular schwannoma in patients with NF2-related schwannomatosis
S Chiranth, SW Langer, HS Poulsen, T Urup
Neuro-Oncology Advances 5 (1), vdad099, 2023
92023
Implementing targeted therapies in the treatment of glioblastoma: previous shortcomings, future promises, and a multimodal strategy recommendation
V Fougner, B Hasselbalch, U Lassen, J Weischenfeldt, HS Poulsen, ...
Neuro-Oncology Advances 4 (1), vdac157, 2022
92022
Angiotensinogen promoter methylation predicts bevacizumab treatment response of patients with recurrent glioblastoma
T Urup, L Gillberg, K Kaastrup, MJS Lü, SR Michaelsen, V Andrée Larsen, ...
Molecular Oncology 14 (5), 964-973, 2020
72020
The system can't perform the operation now. Try again later.
Articles 1–20